Hiral Labs Ltd

Hiral Labs Limited is a WHO-GMP certified pharmaceutical manufacturing company specialising in Oncology and Nutraceutical finished dosage forms (FDF). Established in 2000, Hiral Labs manufactures a diverse range of pharmaceutical formulations, including injections, tablets, capsules, dry syrups, ointments, eye, ear and nasal drops, as well as oral liquids. With a portfolio of over 300 formulations catering to various therapeutic segments, the company operates three dedicated manufacturing plants for Pharmaceutical Dosages, Oncology Injectables, and Nutraceutical Dosages. Notably, their Oncology injectable unit is in compliance with EU standards.

Services include:
- Contract Development and Manufacturing (CDMO)
- Finished Dosage Forms
- Oncology Injectables
- Nutraceutical Dosages

Hiral Labs Limited is renowned for its commitment to quality and excellence in the pharmaceutical sector. With a global presence, exporting products to over 38 countries, the company remains a reliable partner in the industry. To find more information, visit hirallabs.com.